Find Federal Grants
Department of Commerce · NOAA-NOS-ONMS-2021-2006747
Agency for International Development · 7200AA21RFA00011
Office of Naval Research · N00014-21-S-SN03
Office of Science · DE-FOA-0002449
Solar Energy Technologies Office (SETO) Fiscal Year 2021 Systems Integration and Hardware Incubator Funding Program
Golden Field Office · DE-FOA-0002437
Office of Science · DE-FOA-0002456
NASA Headquarters · NNH20ZEA001N-SWS
Proposed Cooperative Institute for Severe and High-Impact Weather Research and Operations
Department of Commerce · NOAA-OAR-CIPO-2021-2006682
Polyplexus Pilot Topic Opportunity Notice for Antennas Crossing Bandwidth Limitations (Topic 25)
DARPA - Defense Sciences Office · HR001119S0075-25
Office of Science · DE-FOA-0002360
National Aeronautics and Space Administration · 80HQTR21NOA01-21NIAC-A2
NASA Johnson Space Center · 80JSC020N0001-OMNIBUS2
National Energy Technology Laboratory · DE-FOA-0002398
NASA Johnson Space Center · 80JSC020N0001-HHCSR
Development of Methods to Evaluate the Impact of Design Differences to the User Interface of Generic Drug-Device Combination Products in Comparison to their Reference Listed Drugs (U01) Clinical Trials Optional
Food and Drug Administration · RFA-FD-21-014
Funding Opportunity Announcement (FOA) for the National Defense Education Program (NDEP) for Science, Technology, Engineering, and Mathematics (STEM), and Biotechnology Education, Outreach, and Workforce Initiative Programs and Enhanced Civics Education
Department of Defense · HQ0034-21-S-F001
“Carbon Capture R&D: Bench Scale Testing of Direct Air Capture Components (TRL 3) and Initial Engineering Design for Carbon Capture, Utilization and Storage Systems from Air (TRL 6)”
National Energy Technology Laboratory · DE-FOA-0002458
Proposed Cooperative Institute to support NOAA Marine Research and Ecosystem Management
Department of Commerce · NOAA-OAR-CIPO-2021-2006680
Physiologically-based pharmacokinetic (PBPK) models to aid the development of generic dermatological products (U01) Clinical Trials Optional
Food and Drug Administration · RFA-FD-21-013